Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-03-01

FDA Approved: MESALAMINE — Supplemental Application (Zydus Lifesciences Limited)

View source ↗

Summary

FDA approved a supplemental application for mesalamine from Zydus Lifesciences Limited, under an ANDA. The approval pertains to a generic product and may includ…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

SUPPL AP for MESALAMINE (MESALAMINE)